Enzymuria in neonates receiving continuous intravenous infusion of gentamicin

Urinary excretion of the tubular enzymes NAG and AAP was investigated during gentamicin treatment of 105 newborn infants. The values found for NAG and AAP show a significant positive correlation. The urinary excretion of NAG was on the average 92% higher during gentamicin treatment as compared with non‐treatment periods in the same newborn infant (33 infants). The same tendency applied to AAP. Newborn infants receiving continuous intravenous infusion of gentamicin were not found to be at greater risk of nephrotoxicity than those receiving intermittent gentamicin treatment, using NAG and AAP as an index of nephrotoxicity. The changes in NAG and AAP within treatment periods were studied. During gentamicin treatment an insignificant average increase in the urinary excretion of NAG occurred, whereas a significant decrease was found during non‐treatment periods. A significant negative correlation was found between urinary excretion of NAG and birth weight/gestational age. The long‐term effect of the higher excretion of NAG and AAP in newborn and adult patients during aminoglycoside treatment is unknown.

[1]  J. John.  What price success? The continuing saga of the toxic:therapeutic ratio in the use of aminoglycoside antibiotics. , 1988, The Journal of infectious diseases.

[2]  A. Fox,et al.  Antibiotic stability in a pediatric parenteral alimentation solution. , 1988, The Journal of pediatrics.

[3]  M. Rybak,et al.  Alanine aminopeptidase and beta 2-microglobulin excretion in patients receiving vancomycin and gentamicin , 1987, Antimicrobial Agents and Chemotherapy.

[4]  J. Langhendries,et al.  Normal values for urinary N-acetyl-beta-glucosaminidase excretion in preterm and term babies. , 1987, Archives of disease in childhood.

[5]  Jerome J. Schentag,et al.  Pharmacokinetics and nephrotoxicity of continuous intravenous infusion of gentamicin in low birth weight infants. , 1986, The Journal of pediatrics.

[6]  S. Donta,et al.  Comparative effects of gentamicin and tobramycin on excretion of N-acetyl-beta-D-glucosaminidase , 1985, Antimicrobial Agents and Chemotherapy.

[7]  M. Le Hir,et al.  Critical evaluation of the diagnostic use of urinary enzymes. , 1984, Contributions to nephrology.

[8]  G. E. Andersen,et al.  Continuous Intravenous Infusion of Ampicillin and Gentamicin during Parenteral Nutrition to 36 Newborn Infants Using a Dosage Schedule , 1984, Acta paediatrica Scandinavica.

[9]  C. Prober,et al.  Aminoglycoside‐related nephrotoxicity in the premature newborn , 1984, Clinical pharmacology and therapeutics.

[10]  G. Mccracken,et al.  Antimicrobial Therapy for Newborns , 1983, 2015 Nelson's Pediatric Antimicrobial Therapy.

[11]  P. Davey,et al.  Study of alanine aminopeptidase excretion as a test of gentamicin nephrotoxicity. , 1983, The Journal of antimicrobial chemotherapy.

[12]  G. Porter.  Nephrotoxic Mechanisms of Drugs and Environmental Toxins , 1982 .

[13]  R. Jagenburg,et al.  Renal function of neonates during gentamicin treatment. , 1982, Archives of disease in childhood.

[14]  D. Deprez,et al.  Validity of N-acetyl-beta-D-glucosaminidase (NAG) determination in assessing netilmicin nephrotoxicity in preterm babies. , 1989, Biology of the neonate.

[15]  P. D'Athis,et al.  Urinary excretion of N-acetyl-glucosaminidase and beta-2-microglobulin as early markers of gentamicin nephrotoxicity in neonates. , 1987, Developmental pharmacology and therapeutics.

[16]  G. Heimann.  Renal toxicity of aminoglycosides in the neonatal period. , 1983, Pediatric pharmacology.

[17]  D. Vidyasagar,et al.  Tobramycin and gentamicin are equally safe for neonates: results of a double-blind randomized trial with quantitative assessment of renal function. , 1982, Pediatric pharmacology.

[18]  U. Ravnskov,et al.  The excretion of N-acetyl-beta-glucosaminidase in glomerulonephritis. , 1981, Clinical nephrology.

[19]  R. Adelman,et al.  Urinary Enzyme Activities in Children and Neonates ReceivingGentamicin Therapy , 1980 .

[20]  J. Scherberich,et al.  Excretion of kidney brush border antigens as a quantitative indicator of tubular damage. , 1979, Current problems in clinical biochemistry.